Loading…

Surgical management of malignant glaucoma: a retrospective analysis of fifty eight eyes

Purpose To assess outcomes of surgical management of malignant glaucoma in terms of re-formation of anterior chamber Methods This was a retrospective analysis of consecutive patients who underwent surgical treatment for malignant glaucoma between January 1995 and December 2013 at a tertiary care oph...

Full description

Saved in:
Bibliographic Details
Published in:Eye (London) 2017-06, Vol.31 (6), p.947-955
Main Authors: Balekudaru, S, Choudhari, N S, Rewri, P, George, R, Bhende, P S, Bhende, M, Lingam, V, Lingam, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To assess outcomes of surgical management of malignant glaucoma in terms of re-formation of anterior chamber Methods This was a retrospective analysis of consecutive patients who underwent surgical treatment for malignant glaucoma between January 1995 and December 2013 at a tertiary care ophthalmic institute, with a minimum follow up of 2 months. Results Fifty eight eyes of 58 patients were included. Fifty two (89.7%) patients had primary angle closure glaucoma. The majority had undergone glaucoma filtration surgery earlier ( n =53, 91.4%). Lensectomy and anterior vitrectomy was performed in 15 (25.9%) eyes (Group 1). Vitrectomy and anterior chamber re-formation was performed in 27 (46.6%) eyes (Group 2). Vitrectomy-phacoemulsification-vitrectomy was performed in 16 (27.6%) eyes (Group 3). Communication between the two segments of eye through anterior hyaloid, lens capsule complex and/or iris was achieved in all groups. The median follow-up (Inter-quartile range) was 30 (71.5) months. Anterior chamber re-formation was achieved in 56 (96.5%) eyes at final visit. The improvement in mean±SD LogMAR visual acuity (1.1±1 to 0.7±0.8) and reduction in number ±SD of anti-glaucoma medications (2.1±1.1 to 1±1.6) between onset and final visit were significant ( P =0.02 and
ISSN:0950-222X
1476-5454
DOI:10.1038/eye.2017.32